Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
etx-018810 (2 trials)
Diabetic Neuropathies (Phase 2)
Neuralgia (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Trials (2 total)
Trial APIs (1 total)